Skip to content

Changes in body composition in patients with cancer in the upper airway and digestive tract: a prospective study

Changes in body composition in patients with cancer in the upper airway and digestive tract: a prospective study - Changes in body composition in head and neck cancer patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34021
Enrollment
60
Registered
2008-01-22
Start date
2008-02-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malnutrition undernutrition

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - malignant tumour in the upper digestive and airway tract: larynx, pharynx or oral cavity - curative treatment with surgery and postoperative radiotherapy, or radiotherapy, or chemoradiation - age 18 year or above - caucasian race - good understanding of dutch language

Exclusion criteria

Exclusion criteria: - palliative treatment - tumor in other region than head and neck region (either secondary primary tumor or metastasis) - amputated arm(s)/leg(s) - oedema as a result of cardial failure, ascites, nefrological or hepatic dysfunction - orthopedic prosthesis (hip or knee) - pacemaker - dementia/mental dysfunction

Design outcomes

Primary

MeasureTime frame
Primary outcome measurement is changes in body composition (fat mass and lean body mass), assessed by: - DEXA (dual energy x-ray absorptiometry). - anthropometerics: skinfold measurements (triceps, biceps, subscapula, supra-iliaca), upper arm (muscle) circumference - hand grip strength - bio-electrical impedance analysis (BIA)

Secondary

MeasureTime frame
Secondary outcome measurements are: - serum levels leptin, adiponectin, FT3, FT4, TSH, IGF-1, IGF-BP3, albumin, prealbumin, transferrin, total cholesterol, CRP, IL-1, IL-6, TNF-a and hemoglobine - presence of symptoms/complaints - performance score

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)